Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene

[1]  Jack R. Davis,et al.  A new candidate region for the positional cloning of the XLP gene , 1998, European Journal of Human Genetics.

[2]  D. Bentley,et al.  Genome mapping by fluorescent fingerprinting. , 1997, Genome research.

[3]  X. Pesesse,et al.  Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. , 1997, Biochemical and biophysical research communications.

[4]  S. Karlin,et al.  Prediction of complete gene structures in human genomic DNA. , 1997, Journal of molecular biology.

[5]  C. Denny,et al.  EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene. , 1996, Oncogene.

[6]  G. Krystal,et al.  Cloning and characterization of human SHIP, the 145-kD inositol 5-phosphatase that associates with SHC after cytokine stimulation. , 1996, Blood.

[7]  P. Tempst,et al.  Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FeγRIIB , 1996, Nature.

[8]  A. Rickinson,et al.  Cytotoxic T lymphocyte responses to Epstein-Barr virus. , 1996, Current opinion in immunology.

[9]  K. Tamai,et al.  Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes , 1996, Nature.

[10]  Carol Soderlund,et al.  SAM: a system for iteratively building marker maps , 1995, Comput. Appl. Biosci..

[11]  K. Klinger,et al.  Increased exon-trapping efficiency through modifications to the pSPL3 splicing vector. , 1995, Gene.

[12]  R. Parmley,et al.  Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. , 1995, The New England journal of medicine.

[13]  T. Osato,et al.  Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Wides,et al.  odd Oz: A novel Drosophila pair rule gene , 1994, Cell.

[15]  E. Gluckman,et al.  Correction of X-Linked Lymphoproliferative Disease by Transplantation of Cord-Blood Stem Cells , 1993 .

[16]  R. Krance,et al.  Correction of Duncan's syndrome by allogeneic bone marrow transplantation , 1993, The Lancet.

[17]  D. Schlessinger,et al.  High-resolution mapping of probes near the X-linked lymphoproliferative disease (XLP) locus. , 1993, Genomics.

[18]  D. Bentley,et al.  Exon structure of the human dystrophin gene. , 1993, Genomics.

[19]  D. Haber,et al.  Characterization of three overlapping deletions causing X-linked lymphoproliferative disease. , 1993, Genomics.

[20]  T. Pawson,et al.  SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.

[21]  D. Bentley,et al.  Construction of a 2.6-Mb contig in yeast artificial chromosomes spanning the human dystrophin gene using an STS-based approach. , 1992, Genomics.

[22]  D. Baltimore,et al.  Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo , 1992, Molecular and cellular biology.

[23]  E. Uberbacher,et al.  Locating protein-coding regions in human DNA sequences by a multiple sensor-neural network approach. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Arthur Weiss,et al.  The zeta chain is associated with a tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phosphoprotein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Jack R. Davis,et al.  The X-linked lymphoproliferative disease: from autopsy toward cloning the gene 1975-1990. , 1991, Pediatric pathology.

[26]  A. Monaco,et al.  Yeast artificial chromosome libraries containing large inserts from mouse and human DNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T Pawson,et al.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.

[28]  W. Sanger,et al.  Partial Xq25 deletion in a family with the X-linked lymphoproliferative disease (XLP) , 1990, Cancer Genetics and Cytogenetics.

[29]  D. Le Paslier,et al.  Construction and characterization of a yeast artificial chromosome library containing seven haploid human genome equivalents. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Riley,et al.  A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones. , 1990, Nucleic acids research.

[31]  N. Bhat,et al.  Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Croce,et al.  Nucleotide sequence analysis of human abl and bcr-abl cDNAs. , 1989, Oncogene.

[33]  W. Sanger,et al.  Chromosome deletion of Xq25 in an individual with X-linked lymphoproliferative disease. , 1989, American journal of medical genetics.

[34]  C. Tyler-Smith,et al.  Construction of yeast artificial chromosome libraries with large inserts using fractionation by pulsed-field gel electrophoresis. , 1989, Nucleic acids research.

[35]  M. Frohman,et al.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Marvin B. Shapiro,et al.  RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. , 1987, Nucleic acids research.

[37]  D. Weisenburger,et al.  Malignant lymphoma in the X‐linked lymphoproliferative syndrome , 1987, Cancer.

[38]  A. Coulson,et al.  Toward a physical map of the genome of the nematode Caenorhabditis elegans. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Klein,et al.  Fatal infectious mononucleosis. , 1980, The New England journal of medicine.

[40]  G. Klein.  The Epstein-Barr virus and neoplasia. , 1975, The New England journal of medicine.

[41]  G. Vawter,et al.  X-LINKED RECESSIVE PROGRESSIVE COMBINED VARIABLE IMMUNODEFICIENCY (DUNCAN'S DISEASE) , 1975, The Lancet.

[42]  G. Klein,et al.  Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx , 1970, Nature.

[43]  M. Epstein,et al.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. , 1964, Lancet.

[44]  B. Trask,et al.  A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locus. , 1997, Genomics.

[45]  D. Schlessinger,et al.  Physical Map and Cosmid Contig Encompassing a New Interstitial Deletion of the X-Linked Lymphoproliferative Syndrome Region , 1996, European journal of human genetics : EJHG.

[46]  Victor V. Solovyev,et al.  Identification of Human Gene Structure Using Linear Discriminant Functions and Dynamic Programming , 1995, ISMB.

[47]  D. Church,et al.  Isolation of genes from complex sources of mammalian genomic DNA using exon amplification , 1994, Nature Genetics.

[48]  A. Jong,et al.  Amplification of gene ends from gene libraries by polymerase chain reaction with single-sided specificity. , 1993, Methods in molecular biology.

[49]  John Kuriyan,et al.  Structures of SH2 and SH3 domains , 1993 .

[50]  B. Blazar,et al.  Allogeneic bone marrow transplantation for X-linked lymphoproliferative syndrome. , 1986, Transplantation.

[51]  A. ALIQUE TOMICO.  [BCG vaccination and tuberculin allergy]. , 1952, Acta pediatrica espanola.